Clinical trials
Phase 1 Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 13 |
| 2012 | 8 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 8 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 84 |
| Terminated | 6 |
| Recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 11 |
| Sanofi | 9 |
| Merck Sharp & Dohme LLC | 6 |
| AstraZeneca | 5 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| NeuroBo Pharmaceuticals Inc. | 3 |
| Novartis Pharmaceuticals | 3 |
| Novo Nordisk A/S | 3 |
| Organon and Co | 3 |
| AJU Pharm Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 102 |
| Dyslipidemias | 17 |
| Hyperlipidemias | 17 |
| Atherosclerosis | 7 |
| Hypertension | 7 |
| Cardiovascular Diseases | 6 |
| Lipid Metabolism Disorders | 4 |
| Metabolic Diseases | 4 |
| Obesity | 4 |
| Coronary Artery Disease | 3 |
Trials
Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.